Applied DNA Sciences, Inc. | WebDisclosure

Basculer en Français

8302	Companies
115146	Keywords
55468	Articles
62542	Press releases

Headlines Articles Press releases Applied DNA Sciences, Inc.

Home
Companies
Applied DNA Sciences, Inc.

BRIEF

published on 05/28/2024 at 15:35, 5 months 24 days ago

Applied DNA annonce le prix d'un appel public à l'épargne de 12 millions de dollars

Investissement Offre Publique Sciences Appliquées De L'ADN Technologie ADN SECONDE
BRIEF

published on 05/28/2024 at 15:35, 5 months 24 days ago

Applied DNA Announces Pricing of $12 Million Public Offering

Investment Applied DNA Sciences SEC Public Offering DNA Technology
PRESS RELEASE

published on 05/28/2024 at 15:30, 5 months 24 days ago

Applied DNA Announces Pricing of $12 Million Public Offering
Applied DNA Sciences, Inc. announces pricing of public offering expected to raise $12.0 million. Offering includes Common Shares, Pre-Funded Warrants, Series A and Series B Warrants. Proceeds to support company's services and general purposes

Financial Services Applied DNA Sciences DNA Technologies Public Offering Stockholder Approval
BRIEF

published on 05/13/2024 at 15:00, 6 months 8 days ago

Les sciences appliquées de l’ADN et l’Institut d’hématologie présenteront une étude révolutionnaire sur la thérapie cellulaire CAR-T

Essais Cliniques Sciences Appliquées De L'ADN Traitement LMA Thérapie Cellulaire CAR-T Fabrication Non Virale
BRIEF

published on 05/13/2024 at 15:00, 6 months 8 days ago

Applied DNA Sciences and Institute of Hematology to Present Revolutionary CAR T-cell Therapy Study

Clinical Trials Applied DNA Sciences CAR T-cell Therapy AML Treatment Non-viral Manufacturing
PRESS RELEASE

published on 05/13/2024 at 14:55, 6 months 8 days ago

Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML
Applied DNA Sciences and IHBT announce abstract on enzyme-based CAR T-cell therapy manufacturing to be presented at EHA 2024 Congress. The study focuses on virus-free CD123-specific CAR T-cells using Linea DNA

Applied DNA Sciences CAR T-cell Therapy IHBT Enzyme-based Manufacturing EHA 2024 Congress
BRIEF

published on 05/10/2024 at 22:10, 6 months 11 days ago

Applied DNA Sciences Reports Decline in Q2 Fiscal Year 2024 Financial Results

Reverse Stock Split Revenue Decline Applied DNA Q2 Financial Results COVID-19 Testing
BRIEF

published on 05/10/2024 at 22:10, 6 months 11 days ago

Les sciences appliquées de l’ADN annoncent une baisse des résultats financiers du deuxième trimestre de l’exercice 2024

Baisse Des Revenus Regroupement D'actions Inversé ADN Appliqué Résultats Financiers Du Deuxième Trimestre Tests COVID-19
PRESS RELEASE

published on 05/10/2024 at 22:05, 6 months 11 days ago

Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results
Applied DNA Sciences, Inc. announces Q2 fiscal 2024 financial results, reporting a decrease in revenues due to COVID-19 testing decline. Operating expenses decrease and loss from operations increases. Stock split completed and Nasdaq compliance regained

Financial Results Nasdaq Compliance Applied DNA Sciences Revenues Decline Operating Expenses
BRIEF

published on 05/10/2024 at 15:05, 6 months 11 days ago

Applied DNA Sciences retrouve sa conformité avec la règle du prix d'offre minimum du Nasdaq

Bourse Règlement Financier Sciences Appliquées De L'ADN Conformité Au Nasdaq ADN Basé Sur La PCR

Accesswire

Published on 11/22/2024 at 00:00, 8 hours 8 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 10 hours 3 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 10 hours 18 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 11 hours 53 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals
Published on 11/21/2024 at 20:10, 11 hours 58 minutes ago

For Us TV Productions, a Portfolio Company of Belle Bonica Luxe Corp., Invites BIPOC Filmmakers and Producers to Join Its Inclusive Streaming Platform

View all ACCESSWIRE

EQS Group

Published on 11/22/2024 at 07:45, 23 minutes ago

Preliminary figures for financial year 2023/24 // Significant increase in profitability // Guidance achieved at all levels // Forecast 2024/25
Published on 11/22/2024 at 07:30, 38 minutes ago

Pyrum Innovations AG publishes figures for the first nine months of 2024
Published on 11/22/2024 at 07:30, 38 minutes ago

Market entry in Belgium: cyan AG is launching a cooperation with Orange Belgium and realizing new growth opportunities
Published on 11/22/2024 at 07:30, 38 minutes ago

EQS-Adhoc: All for One Group SE resolves on Share Buyback Programme with a volume of up to EUR 7 million
Published on 11/22/2024 at 07:23, 45 minutes ago

EQS-Adhoc: Entering into agreements for the acquisition of a majority stake in OTRS AG by Optimus BidCo AG, an acquisition company of Easyvista SAS, for a purchase price of EUR 17 per share

Les Echos

Published on 11/21/2024 at 06:58, 1 day 1 hour ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 1 hour ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 1 hour ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 12 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 12 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE